BIOLASE names Dr. Russell Morrow as Chief Dental Officer
BIOLASE, Inc. recently announced the appointment of Dr. Russell Morrow, D.D.S. as Chief Dental Officer, effective Nov. 1, 2022. Dr. Samuel Low, who has served in that role since 2016, will take on a new role as vice president of clinical strategic alliances and will focus on building partnerships and growth with Dental Service Organizations (DSOs), universities and government institutions.
According to a news release, Morrow has been practicing dentistry for over 15 years in a variety of practice types and settings. His most recent role as regional doctor mentor of operations for Heartland Dental, the nation’s largest DSO, included overseeing the growth of over 60 doctors in three states as well as providing mentorship for hundreds of dentists throughout the U.S.
Morrow is passionate about the use of lasers in dental treatment and teaches certification classes for both hard and soft tissue lasers. He is a dental examiner for the Western Regional Examination Board and currently serves on the Arizona State Dental Board appointed by Governor Ducey and the Dental Exam Review Board.
Originally from Salt Lake City, Utah, Morrow attended New York University College of Dentistry where he earned his Doctor of Dental Surgery degree.
Learn more about BIOLASE on the company’s website: https://www.biolase.com/
Related articles
News 05 December 2025
BIOLASE, the global leader in dental lasers, announced its participation in the 2025 Greater New York Dental Meeting (GNYDM), taking place November 28–December 3 in New York City.
News 28 October 2025
BIOLASE, the global leader in dental laser technology, will present a major advancement in periodontal care during the American Academy of Periodontology (AAP) 2025 Corporate Forum in Toronto,...
News 25 September 2025
BIOLASE, the global leader in dental laser technology, proudly announces a new chapter in its history following its acquisition by MegaGen Implant.
Products 20 December 2023
BIOLASE announced it has been awarded a Top Workplaces 2023 honor by Orange County Register Top Workplaces. The award is based solely on employee feedback gathered through a third-party survey...
Market 01 December 2022
Growth is expected due to demand for cosmetic dentistry and expansion of emerging markets worldwide.
Read more
CaviSense Inc., a Harvard/Tufts spin-out and developer of a radiation-free diagnostic technology for active tooth demineralization.
Colgate-Palmolive (NYSE:CL) Chief Operating Officer, Americas, Shane Grant, and Executive Vice President, M&A and Special Projects, John Faucher, will participate in a fireside cha
News 26 May 2026
With just five weeks to go, Dentsply Sirona’s Implant Solutions World Summit 2026 is seeing strong global demand, with registration continuing to grow and most masterclasses now fu
Editorials 26 May 2026
End of an era: Miller will retire May 31 after more than 50 years at Texas A&M College of Dentistry
If anyone needs a new smile or a history lesson about Texas A&M College of Dentistry in Dallas, Dr.
Oral pathology 26 May 2026
This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
Copyright © 2026 - All Rights Reserved
ISSN 2767-1178